Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery

Briere, DA; Bueno, AB; Gunn, EJ; Michael, MD; Sloop, KW

Sloop, KW (reprint author), Eli Lilly & Co, Lilly Res Labs, Diabet & Complicat, Indianapolis, IN 46285 USA.

DIABETES, 2018; 67 (2): 309

Abstract

Therapeutic engineering of glucagon-like peptide 1 (GLP-1) has enabled development of new medicines to treat type 2 diabetes. These injectable analogs......

Full Text Link